Literature DB >> 20919616

Advanced airway management--a medical emergency response team perspective.

A G Haldane1.   

Abstract

OBJECTIVES: To determine the number of medical emergency response team (MERT) patients undergoing advanced airway management in the peri-evacuation phase and to determine the indications for airway interventions undertaken in flight.
METHODS: This was a retrospective study. Data was collected from patient report and mission debrief forms completed after each MERT mission during Operation HERRICK 10 (April-October 2009). All patients that received advanced airway interventions before or during evacuation were identified.
RESULTS: MERTs were involved in the primary transfer of 534 patients during the period studied, 56 (10.5%) underwent advanced airway management, of which 31 (5.8% of total) were initiated by the MERT in the peri-evacuation phase. Twenty five cases (4.7%) underwent advanced airway management by other pre-hospital providers prior to MERT arrival. Of the 31 advanced airway interventions undertaken in-flight, cardiac arrest was the primary indication in only nine cases.
CONCLUSIONS: The figure of 56 patients requiring advanced airway management is at the higher end of the range expected from the study of historical military data. This may reflect the doctrine of "intelligent tasking", that is sending this physician-led team to the most seriously injured casualties.

Entities:  

Mesh:

Year:  2010        PMID: 20919616     DOI: 10.1136/jramc-156-03-06

Source DB:  PubMed          Journal:  J R Army Med Corps        ISSN: 0035-8665            Impact factor:   1.285


  2 in total

1.  Human factors in decision making in major trauma in Camp Bastion, Afghanistan.

Authors:  G S Arul; H E J Pugh; S J Mercer; M J Midwinter
Journal:  Ann R Coll Surg Engl       Date:  2015-05       Impact factor: 1.891

2.  Does medical emergency team intervention reduce the prevalence of emergency endotracheal intubation complications?

Authors:  Go-Woon Kim; Younsuck Koh; Chae-Man Lim; Myongja Han; Jiyoung An; Sang-Bum Hong
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.